ka.haddad
TL2 Moderator · Dhaka
Contributes reviews on supplier material. Based in Dhaka.
Joined 10 May 2025 · last posted 7d
91Posts here
4Topics
0Solutions
115Likes received
168Likes given
18Badges
69Days visited
836Posts read
Recent activity
Full stream-
Revisiting: How this community labels and discusses unrefereed work Replied, post #30 · Evidence › Preprints · 21 Jul 2026 · 5 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Submitting a sample: the process end to end Replied, post #96 · Sourcing › Independent verification · 20 Jul 2026 · 2 likes post #95 answers the question as asked. The question underneath it is different. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #93 · Compounds › Repair & healing peptides · 18 Jul 2026 · 25 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #61 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #33 · Start Here › Welcome · 12 Jul 2026 · 1 like post #32 is right about the mechanism and I think understates the practical bit. The compound and evidence pages are updated regularly and they are worth reading when…
-
Prescription portability between countries Replied, post #95 · Access › International · 11 Jul 2026 · 18 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
What to include when your question involves a chromatogram — one year on Replied, post #71 · Start Here › How to Ask · 10 Jul 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #82 · Practice › Interactions · 10 Jul 2026 · 32 likes Picking up post #79: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #18 · Clinical › Comorbidities · 10 Jul 2026 · 1 like This follows post #15 rather than contradicting it. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance.…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #8 · Access › Insurance & coverage · 7 Jul 2026 · 12 likes I read post #6 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
-
Coming back to: Time to steady state after a dose increase Replied, post #89 · Pharmacology › Pharmacokinetics · 30 Jun 2026 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
CJC-1295 with and without DAC: what the modification does Replied, post #94 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 15 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…